Industry

YC Therapeutics Companies

57 Y Combinator therapeutics startups with verified founder contacts, batch info, and company data.

Companies

Active

Acquired

Public

YC Company Directory

50 companies

Export All

Company	Batch	Description	Status	Location	Team	Founders	Reveal
Exin Therapeutics	W25	AI drug discovery platform for neurotherapeutics	Active	San Francisco, CA, USA	3	Gabriel Ocana Santero, Ivan Lazarte, Marko Tvrdic	Reveal
Uncommon Therapeutics	W25	A Disease Focused Biotech, Building Multiple Billion Dollar Drugs	Active	San Francisco, CA, USA	2	Noah Auerhahn, Ryan Lim	Reveal
Eris Biotech	W24	Our drugs engage the immune system to fight tumors	Active	Lehi, UT, USA	2	Rachel Garlick, Evita Weagel	Reveal
Granza Bio	W24	Reprogramming Immunity for Target-Specific Medicines	Active	San Francisco, CA, USA	7	Ashwin Nandakumar, Ashwin Jainarayanan	Reveal
Junction Bioscience	W24	AI Hypothesis Engine for Molecular Discovery	Active	—	1	Brian Petkov	Reveal
ParcelBio	W24	Next-generation mRNA medicines	Active	—	5	David Weinberg, Chris Carlson	Reveal
SynsoryBio	W24	"If-then" conditional logic for protein drugs	Active	Cambridge, MA, USA	2	Elliot Tague, Nathan Tague	Reveal
Velorum Therapeutics	W24	Breakthrough medicines unlocking the biology of heme	Active	San Francisco, CA, USA	5	Pouya Modareszadeh, Parsa Modareszadeh	Reveal
Modulari-T	W23	We teach your immune system to attack and cure cancer	Active	Montreal, QC, Canada	4	David White, Stephanie Mok	Reveal
Alixia	W22	Targeting the Tumor Ecosystem to address cancer drug resistance.	Active	San Francisco, CA, USA	2	Olof Mollstedt, Helen Chen	Reveal
Origami Therapeutics, Inc.	W22	Oral drugs to halt neurodegeneration	Active	San Diego, CA, USA	4	Beth Hoffman	Reveal
Biodock	W21	Cloud AI microscopy automation	Active	Austin, TX, USA	8	Nurlybek Mursaliyev	Reveal
Entelexo Biotherapeutics	W21	Creating a New Class of Drugs to Address Incurable Autoimmune Diseases	Active	Irvine, CA, USA	3	MILAD RIAZIFAR, Todd Schurr, Cameron Taylor	Reveal
Nuntius Therapeutics	W21	Cell-specific genetic medicines	Active	London, UK	2	Benita Nagel, Albert Kwok	Reveal
PipeBio	W21	PipeBio is a SaaS bioinformatics platform to develop antibody drugs.	Acquired	Aarhus, Denmark	10	Owen Bodley, Jannick Bendtsen	Reveal
Serna Bio	W21	Genetic Medicine with Small Molecules	Active	Ontario, CA, USA	5	Rabia Khan	Reveal
Valink Therapeutics	W21	Discovering bispecific antibody drug-conjugates (BsADC) against cancer	Active	Boston, MA, USA	15	Arne Scheu, Irsyad Khairil	Reveal
Altay Therapeutics	W20	Altay develops disease-modifying therapies targeting transcription…	Active	San Carlos, CA, USA	6	Ali Ozes, Osman Ozes	Reveal
Equator Therapeutics	W20	We are developing a drug to burn calories and increase metabolism…	Active	San Francisco, CA, USA	2	Liliya Khasin, Yuriy Kirichok, Jonah Sinick	Reveal
Ochre Bio	W20	RNA medicines for liver diseases	Active	Oxford, UK	50	Quin Wills	Reveal
OpenBiome	W20	A nonprofit stool bank enabling access to fecal transplants.	Active	Cambridge, MA, USA	70	Majdi Osman, Carolyn Edelstein	Reveal
1910	W19	Multimodal AI Platform for Modality Agnostic Drug Discovery™	Active	Boston, MA, USA	20	Jen Asher	Reveal
Endpoint Health	W19	Precision-first therapies	Active	Palo Alto, CA, USA	23	Diego Rey, Jeff Osborn, Jason Springs, Leonardo Teixeira	Reveal
Excepgen	W19	—	Active	San Francisco, CA, USA	3	Thomas Folliard	Reveal
Intact Therapeutics	W19	Smart gels for local drug delivery to the gut	Active	Palo Alto, CA, USA	4	Ravi Pamnani, Sidhartha Sinha	Reveal
LEAH Labs	W19	Living therapies for pets first, and their people next	Active	Minneapolis, MN, USA	4	Wesley Wierson	Reveal
ResistanceBio	W19	We solve drug resistance for cancer	Inactive	Menlo Park, CA, USA	15	Nicholas Goldner, Christopher Bulow	Reveal
YourChoice Therapeutics	W19	YourChoice therapeutics is revolutionizing the contraceptive market…	Active	Berkeley, CA, USA	3	Akash Bakshi, Nadja Mannowetz	Reveal
Mind Emulation Foundation	W18	—	Active	—	1	Dan Siroker	Reveal
Persephone Biosciences	W18	We are using the gut microbiome to end cancer.	Active	San Diego, CA, USA	6	Stephanie Culler, Stephen Van Dien	Reveal
Tradewind BioScience	W18	Tradewind translates scientific insight into innovative ways of…	Active	San Francisco, CA, USA	2	Thaddeus Allen	Reveal
Sigma Genetics	W17	Sigma Genetics is a biotechnology company that is building…	Active	Seattle, WA, USA	2	Karen Eaton, Matthew Scholz, Chris Pihl	Reveal
Sigma Genetics	W17	Sigma Genetics is a biotechnology company that is building…	Active	Seattle, WA, USA	2	Karen Eaton, Matthew Scholz, Chris Pihl	Reveal
Blank Bio	S25	RNA-based AI for better drugs and smarter clinical trials.	Active	San Francisco, CA, USA	3	Jonny Hsu, Philip Fradkin, Ian Shi	Reveal
Evolvere BioSciences	S24	Making Next-Generation Antibiotics that Outpace Bacterial Evolution	Active	Oxford, UK	3	Adam Winnifrith, Piotr Jedryszek, Weronika Slesak	Reveal
Kopra Bio	S24	Genetically engineered viruses that teach your immune system to kill…	Active	San Francisco, CA, USA	2	Alexander Haddad	Reveal
Eugit Therapeutics	S22	Enabling Tissue Targeting of Therapies	Active	San Carlos, CA, USA	2	Nizar Batada	Reveal
Guardian Bio	S22	Dendritic cell-based platform for cancer therapy	Active	Boston, MA, USA	2	Ananya Zutshi, Ricky Barrett	Reveal
Keylika	S22	Redefining the Standard of Care for Iron Deficiency Anemia	Active	Walnut Creek, CA, USA	1	Buddha Chaudhuri, Frederik Ceyssens	Reveal
Relevium Medical	S22	Platform injectable gel based therapeutic for osteoarthritis	Active	Galway, Ireland	5	Alison Liddy	Reveal
Serinus Biosciences	S22	Combinations therapy by rational design	Active	New York, NY, USA	6	Adam Yaari, Maxwell Sherman	Reveal
Catena Biosciences	S21	Using protein coupling to build new therapies	Active	Berkeley, CA, USA	7	Marco Lobba, Matthew Francis	Reveal
Humane Genomics	S21	A platform to make artificial viruses as cancer therapeutics.	Active	New York, NY, USA	5	Peter Weijmarshausen, Chad Moles	Reveal
Inflow	S21	A self-help app for people to manage their ADHD.	Active	London, UK	20	Levi Epstein, Seb Isaacs	Reveal
Medium Biosciences	S21	AI-designed Protein Therapeutics	Active	San Francisco, CA, USA	6	Adil Yusuf, Mohamed Hassan Kane	Reveal
Promakhos Therapeutics	S21	A therapeutics platform for curing inflammatory disorders	Active	Boston, MA, USA	2	Katerina Chatzi, Jasper Edgar Neggers	Reveal
Sensible Biotechnologies	S21	Unlocking the next generation of mRNA medicines	Active	Oxford, UK	24	Miroslav Gasparek, Marian Kupculak	Reveal
SFA Therapeutics	S21	Regulating the immune system to block cancer & autoimmune diseases	Active	Philadelphia, PA, USA	4	Ira Spector, Alla Arzumanyan, Mark Feitelson	Reveal
Kernal Biologics	S20	Kernal is creating mRNA 2.0 therapies that work in specific cells	Active	Cambridge, MA, USA	20	Yusuf Erkul, Jeff Ozdemir, Burak YILMAZ	Reveal
Asher Bio	S19	We build better immunotherapies	Active	San Carlos, CA, USA	3	Ivana Djuretic, Andy Yeung	Reveal

Batch Distribution

WW252 WW246 WW231 WW222 WW216 WW204

Status Breakdown

Active53 Acquired2 Inactive2

Top Locations

San Francisco11 Boston4 San Carlos4 Palo Alto4 Cambridge3 Oxford3

About YC Therapeutics Companies

Y Combinator has funded 57 therapeutics companies since its founding in 2005. These startups span from early-stage pre-launch to publicly traded companies, making YC one of the most prolific backers of therapeutics innovation globally.

53 of these companies are currently active. 2 have been acquired. VCBacked tracks verified founder contact information, team sizes, and company status for every YC therapeutics startup.

Related Industries

B2B641 Engineering, Product and Design139 Industrials89 Consumer80 Healthcare78 Fintech65 Infrastructure64 Productivity38

← All YC Companies

Get the full therapeutics dataset

Verified founder emails, CSV export, and advanced filters for all 57 YC therapeutics companies.

No credit card required